Skip to content

Triglycerides can normalise after switch from d4T to tenofovir

Less than 40% of HIV-positive Swiss cohort have CD4 cell count above 500 after four years of HAART

Don't use tenofovir, ddI, 3TC combination warns Gilead

Starting HAART at low CD4 count can mean that functional immune response blunted

Lymph node removal may extend treatment interruption, suggest US research groups

Kaletra monotherapy: unorthodox but effective regimen challenges the rules

Once-daily abacavir safe and effective - ICAAC late breaker

Abacavir leads to better CD4 increase than AZT when combined with 3TC and EFV

Warning on atazanavir and tenofovir combination